Only ~14% Of U.S. Adults Have Gotten Latest Covid-19 Vaccine Update
![[Post New]](/jforum/templates/default/images/icon_minipost_new.gif){kind=icon}
Anonymous
Of course there is. There always has been. The vast majority of people have not been willing to mask to reduce the risk of fairly mild illnesses, and that's not going to change. |
Anonymous
We understand the whole “we can’t let masks and Covid control our lives”, and we can’t “stop living” but at the same time we don’t have to pretend that Covid is a “mild “illness. |
Anonymous
For the vast majority of people, it is. |
Anonymous
Not true. I’m wondering what your definition of “mild “is. |
Anonymous
DP. Here’s how the NIH defines mild, and indeed, most cases fall under this category. ‘The National Institutes of Health guidelines for treatment categorize mild COVID as “individuals who have any of the various signs and symptoms of COVID-19 (e.g., fever, cough, sore throat, malaise, headache, muscle pain, nausea, vomiting, diarrhea, loss of taste and smell) but who do not have shortness of breath, dyspnea (difficult or labored breathing), or abnormal chest imaging."’ |
Anonymous
Yes for most people it is mild. As long as you’re not a man child |
Anonymous
OP's post might finally be accurate. Best guess is that around 14% of US adults have now received the new covid booster as of February. That is significantly under the 22% figure cited currently by the CDC, based on its NIS phone survey. It is remarkable that the CDC cites NIS results without ever acknowledging how wildly distorted its estimates are. When you compare actual state data with NIS estimates, it appears that CDC/NIS is overstating actual US booster uptake by at least 8 percentage points, more than a 50% overstatement. The CDC has a more accurate series based on actual vaccination data, IQVIA, which shows around 12% of US adults having received the booster. IQVIA tends to mildly understate totals, but is much closer to actual than NIS estimates. Unfortunately, the CDC opts to report IQVIA data in raw numbers which preempts an easy comparison with NIS shares. In public presentations, the CDC cites the wildly inflated NIS share estimates. CDC NIS covid vaccine phone survey estimates: https://www.cdc.gov/vaccines/imz-managers/coverage/covidvaxview/interactive/adult-coverage-vaccination.html CDC IQVIA actual covid vaccine data: https://www.cdc.gov/vaccines/imz-managers/coverage/covidvaxview/interactive/adult-vaccinations-administered.html % of Adult Population Receiving New Covid Booster NY Data: 14%, CDC NY Phone Survey 23% -- CDC Overstatement 9% Virginia Data: 14%, CDC VA Phone Survey 27% -- CDC Overstatement 13% Florida Data*: 9%, CDC FL Phone Survey 16% -- CDC Overstatement 7% California Data*: 16%, CDC CA Phone Survey 25% -- CDC Overstatement 9% * These states report all population boosted shares; 2 percentage points were added to state reported shares to proxy adult shares NY: https://coronavirus.health.ny.gov/updated-covid-19-vaccination-data VA: https://www.vdh.virginia.gov/epidemiology/respiratory-diseases-in-virginia/data/vaccines/ FL: https://www.flhealthcharts.gov/ChartsDashboards/rdPage.aspx?rdReport=Covid19.Dataviewer CA: https://covid19.ca.gov/vaccination-progress-data/#overview |
Anonymous
|
I will bet the iron lung manufacturers will be sending money to Trump and RFK Jr.
Oh dear they are actually doing just that Maga anti vax idiots Yes they are going to start manufacturing again |
Anonymous
| I’ll say I didn’t get the most recent booster because I couldn’t find the time to take 2 consecutive days off work (educator) and I selfishly didn’t want to give up a weekend. I get so so sick from the shots my boss sent me home last time I tried to come to work after getting one. I probably should’ve just given up one weekend instead of risking Covid though. |
Anonymous
This has been repeated a few times, but Novavax doesn't give people side effects and is a very effective vaccine. I had a sore arm but nothing else (similar to a flu shot) |
Anonymous
|
This thread debated how this winter's covid season would compare to last year. We now have that data. This year's covid hospitalizations and deaths followed exactly the same pattern as last year; hospitalizations peaked the first week of January and deaths peaked in early/mid January. Looking at cumulative weekly data since the start of October, this season's covid hospitalizations were down 25% and covid deaths were down 40% relative to last year. This reflects the fact that current variants are milder than earlier variants and that most of the population has now had covid at least once.
The moderating trend in covid hospitalizations and deaths was apparent throughout the winter season, which is why the CDC's urgent Health Advisory warning in December about the risks of severe disease due to low vaccination rates was so odd. This season's moderation in covid hospitalizations and deaths occurred despite minimal uptake of the new booster. New Covid Hospitalizations https://covid.cdc.gov/covid-data-tracker/#trends_weeklyhospitaladmissions_select_00 New Covid Deaths https://covid.cdc.gov/covid-data-tracker/#trends_weeklydeaths_select_00 |
Anonymous
PP again. The CDC has released preliminary rankings for leading causes of death in 2023. Covid barely made the top ten. It was ranked #10 with 49,707 deaths. Flu and pneumonia were #11 with 44,751 deaths. https://wonder.cdc.gov/controller/saved/D176/D374F608 The moderation in covid deaths is one factor the CDC cited in dropping its covid-specific policies (ie isolation), opting instead to harmonize its covid guidance with that of other respiratory illness. |
Anonymous
|
Underreporting vs. previous years may have skewed these numbers.
Sure would be nice if we had a competent, trustworthy government. Good luck out there, folx. |
Anonymous
Exactly this. |
Anonymous
| Aren’t we all dead from Covid and this is a matrix anyways? |